Arecor Therapeutics (LSE:AREC) Median PS Value : £0.00 (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Arecor Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.15. Arecor Therapeutics's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is £0.00.

As of today (2024-06-14), Arecor Therapeutics's share price is £1.275. Arecor Therapeutics's Median PS Value is £0.00. Therefore, Arecor Therapeutics's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Arecor Therapeutics's Median PS Value or its related term are showing as below:

LSE:AREC's Price-to-Median-PS-Value is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.66
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Arecor Therapeutics Median PS Value Historical Data

The historical data trend for Arecor Therapeutics's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics Median PS Value Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

Median PS Value

Get a 7-Day Free Trial

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Median PS Value	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Arecor Therapeutics's Median PS Value

For the Biotechnology subindustry, Arecor Therapeutics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's Price-to-Median-PS-Value falls into.

Arecor Therapeutics Median PS Value Calculation

Arecor Therapeutics's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.15	*	0
	=	0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arecor Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.15.

Arecor Therapeutics (LSE:AREC) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Arecor Therapeutics's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	1.275	/	0.00
	=

Arecor Therapeutics Median PS Value Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.